New eye injection shows promise for diabetic vision loss
NCT ID NCT05697809
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This phase 2 trial tested a new way to deliver dexamethasone directly to the back of the eye using tiny microspheres (OXU-001) compared to the standard Ozurdex implant. The study enrolled only 3 adults with diabetic macular edema to check safety and how well the treatment is tolerated. The goal is to see if this new method can provide longer-lasting relief with fewer side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
dexamethasone microspheres (OXU-001)
What this could lead to
If successful, this could offer a longer-lasting treatment option for diabetic macular edema with fewer injections.
What could go wrong
This is a very small early-phase trial (only 3 participants) focused on safety, so efficacy is not yet established. The new delivery method may carry risks like eye inflammation or infection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC MACULAR EDEMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Blue Ocean Clinical Research West
Clearwater, Florida, 33761, United States
-
Emmanuelli Research and Development Center, LLC
Arecibo, 00612, Puerto Rico
-
Retina Consultants of Minnesota
Minneapolis, Minnesota, 55337, United States
-
Retina Consultants of Texas
Houston, Texas, 77380, United States
-
Retinal Consultants of Texas - San Antonio
San Antonio, Texas, 78240, United States
-
Retinal Research Institute, LLC
Phoenix, Arizona, 85053, United States
-
Sierra Eye Associates
Reno, Nevada, 89502, United States
-
University Retina and Macula Associates
Oak Forest, Illinois, 60452, United States
-
Valley Retina Institute, PA
McAllen, Texas, 78503, United States